Elizabeth Glaser Pediatric AIDS Foundation

Elizabeth Glaser Pediatric AIDS Foundation
Name	Elizabeth Glaser Pediatric AIDS Foundation
Formation	1988
Founder	Susan DeLaurentis; Paul Glaser
Type	Nonprofit organization
Headquarters	Los Angeles, California
Region served	Global
Focus	Pediatric HIV/AIDS prevention, treatment, research

Elizabeth Glaser Pediatric AIDS Foundation is a nonprofit organization founded in 1988 focused on preventing pediatric HIV infection, treating children living with HIV, and supporting families affected by HIV/AIDS. The organization was established after a high-profile transmission case drew attention from medical, philanthropic, and entertainment communities, prompting engagement from public health institutions, international agencies, and research networks. It has worked with academic centers, national health ministries, global funders, and advocacy groups to expand pediatric antiretroviral access and eliminate mother-to-child transmission.

History

The organization was established in 1988 by family members and allies following a well-publicized infection case that involved actors and healthcare professionals; founders drew on networks including Susan DeLaurentis, Paul Glaser, and celebrity advocates tied to Hollywood and Los Angeles. Early collaborations included referrals to clinicians at University of California, Los Angeles and researchers at National Institutes of Health and Centers for Disease Control and Prevention who were engaged with pediatric HIV cohorts and perinatal transmission studies. Through the 1990s the group partnered with academic centers such as Johns Hopkins University School of Medicine and Harvard Medical School investigators participating in clinical trials coordinated by groups like Pediatric AIDS Clinical Trials Group and international consortia linked to World Health Organization. In the 2000s the organization expanded programs in countries with high HIV prevalence, aligning with national efforts in South Africa, Zimbabwe, India, and Nigeria and coordinating with donor institutions such as President's Emergency Plan for AIDS Relief and Global Fund to Fight AIDS, Tuberculosis and Malaria.

Mission and Programs

The foundation's mission centers on preventing pediatric HIV, ensuring treatment for children, and supporting families, working across prevention, care, treatment, and community support. Programmatic activities include prevention of mother-to-child transmission initiatives implemented with ministries like Ministry of Health (South Africa), pediatric antiretroviral delivery aligned with guidelines from World Health Organization and United Nations Children's Fund, and psychosocial services linked to community-based partners such as Treatment Action Campaign and local non-governmental organizations. Service delivery models have integrated task-shifting strategies promoted by Paul Farmer-affiliated organizations and implementation science frameworks used by centers including London School of Hygiene & Tropical Medicine and Columbia University. Training and capacity building engaged nursing colleges, medical schools like University of Cape Town and All India Institute of Medical Sciences, and laboratory networks associated with FIND (Foundation for Innovative New Diagnostics).

Research and Impact

Research supported or conducted in collaboration with the foundation has influenced clinical guidelines and policy by contributing evidence from perinatal HIV transmission trials, pediatric pharmacology studies, and operational research. Collaborative research partners included National Institutes of Allergy and Infectious Diseases, Pediatric HIV/AIDS Cohort Study, and universities such as University of Pennsylvania and University of Cambridge, producing data informing antiretroviral regimen choices endorsed by World Health Organization and American Academy of Pediatrics. Implementation outcomes in high-burden settings were evaluated with analytical methods used by Bill & Melinda Gates Foundation-funded teams and global modeling groups at Imperial College London. Impact metrics tracked reductions in vertical transmission rates in program countries, increases in pediatric treatment coverage reported to UNAIDS, and integration of early infant diagnosis using assays developed by firms and consortia connected to Abbott Laboratories and Roche Diagnostics.

Advocacy and Policy

Advocacy work has targeted elimination of mother-to-child transmission through engagement with multilateral agencies and national legislatures, leveraging relationships with UNAIDS, United Nations General Assembly Special Session on HIV/AIDS, and US policy mechanisms including United States Congress appropriations committees for PEPFAR. The foundation has participated in coalitions with civil society organizations such as Global Network of People Living with HIV and professional societies like International Pediatric Association to shape policy on pediatric antiretroviral approvals, pricing negotiations involving pharmaceutical companies like Gilead Sciences and ViiV Healthcare, and regulatory pathways overseen by U.S. Food and Drug Administration and European Medicines Agency. Campaigns included advocacy at global health forums including Global Fund replenishment conferences and World Health Assembly meetings.

Funding and Partnerships

Funding sources have included philanthropic donors such as Bill & Melinda Gates Foundation, government programs including PEPFAR and bilateral agencies like United States Agency for International Development, and multilateral grants from Global Fund to Fight AIDS, Tuberculosis and Malaria. Partnerships span academic research centers (for example, Imperial College London and Johns Hopkins Bloomberg School of Public Health), clinical networks such as Elizabeth Glaser Pediatric AIDS Foundation-associated collaborators, and corporate partners involved in diagnostic and pharmaceutical supply chains like Abbott and Roche. The organization also engaged celebrity and entertainment industry partners including figures associated with Hollywood advocacy networks to raise awareness and resources.

Criticism and Controversies

The foundation has faced scrutiny typical of large global health NGOs concerning program sustainability, donor dependence, and prioritization of services, with critiques voiced in analyses by public health scholars at institutions such as Harvard T.H. Chan School of Public Health and commentator outlets. Debates have involved balance between vertical pediatric programs versus integrated primary care promoted by advocates linked to Médecins Sans Frontières and health systems researchers at London School of Hygiene & Tropical Medicine. Financial transparency and grant management reviews have been compared against nonprofit standards endorsed by oversight entities like Charity Navigator and regulatory frameworks in jurisdictions including California Attorney General filings. Some controversies centered on cost-effectiveness discussions highlighted in global health journals and policy forums at World Health Assembly panels.

Category:HIV/AIDS organizations Category:Non-profit organizations based in Los Angeles